Bottom line
Is TCVAX a good fund? The bottom line
TCVAX is the Class A share class of Touchstone Mid Cap Value Fund, an actively managed mid-cap mutual fund from Touchstone.
Its expense ratio is 1.17% — about $117 a year on every $10,000 invested, more expensive than 75% of mid-cap funds we track.
It returned +4.1% over one year, +7.0% a year over five years, +7.9% a year over ten (as of Dec 31, 2025, per its prospectus).
With $571 million in net assets and 73 holdings, its largest position is Regal Rexnord Corp (3.3%) and the top 10 make up 25.5% of the portfolio.
This share class carries a front-end sales charge of up to 5%; a no-load class or ETF alternative can avoid it.
What to watch
- Expensive for its category (1.17%)
- Front-end sales load up to 5%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What TCVAX invests in
The Touchstone Mid Cap Value Fund (the Fund) seeks capital appreciation.
The Fund invests, under normal conditions, at least 80% of its net assets (including borrowings for investment purposes) in common stocks of companies with medium market capitalizations. This is a non-fundamental policy that the Fund can change upon 60 days prior notice to shareholders. For purposes of the Fund, a medium capitalization company has a market capitalization within the range of market capitalization represented in the Russell Midcap Value Index (between $1.31 billion to $101.87 billion as of December 31, 2025) at the time of purchase. The size of the companies in the Russell Midcap Value Index will change with market conditions. The Fund will hold approximately 60 to 80 securities. The Fund's sub-adviser, Leeward Investments, LLC (Leeward), employs a fundamental investment process which seeks to identify companies which it believes are selling at a discount to their…
From the fund's prospectus (filed Jan 27, 2026).
TCVAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| TCVAX | +4.1% | +7.0% | +7.9% |
| Mid-Cap median | +7.9% | +8.1% | +9.9% |
Source: Fund prospectus, as of Dec 31, 2025
What TCVAX costs
On a $10,000 investment, TCVAX's 1.17% expense ratio costs about $117 a year. The prospectus estimates $2,038 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.
TCVAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Regal Rexnord Corp RRX | 3.31% |
| 2 | Wesco International Inc WCC | 3.09% |
| 3 | Keysight Technologies Inc KEYS | 2.92% |
| 4 | Microchip Technology Inc MCHP | 2.66% |
| 5 | Clean Harbors Inc CLH | 2.48% |
| 6 | Short-term Investments Trust | 2.44% |
| 7 | Rogers Corp ROG | 2.34% |
| 8 | Lumentum Holdings Inc LITE | 2.22% |
| 9 | Aramark ARMK | 2.05% |
| 10 | First Horizon Corp FHN | 2.01% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 25.5% of the fund. See all top 25 holdings and asset mix →